SCHEMBL1974251

SCHEMBL1974251

c1ccc(-c2c(-c3ccccc3)c(-c3ccccc3)c3c(-c4ccccc4)c4cc5cc6ccccc6cc5cc4c(-c4ccccc4)c3c2-c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 10/20 0.47
ESR2 Q92731 8/20 0.47
MAPT P10636 3/20 0.39
ALDH1A1 P00352 2/20 0.39
CYP3A4 P08684 2/20 0.39
HSD17B10 Q99714 2/20 0.39
LMNA P02545 2/20 0.39
KDM4E B2RXH2 2/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
ALOX15 P16050 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
HBB P68871 1/20 0.35
HIF1A Q16665 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1117215 0.92 ESR1 (0.49) ESR1ESR2MAPTALDH1A1CYP3A4
SCHEMBL31508271 0.89 ESR1 (0.52) ESR1ESR2MAPTALDH1A1CYP3A4
SCHEMBL27587540 0.89 ESR1 (0.52) ESR1ESR2MAPTALDH1A1CYP3A4
SCHEMBL364085 0.89 ESR1 (0.52) ESR1ESR2MAPTALDH1A1CYP3A4
SCHEMBL4316535 0.87 ESR1 (0.55) ESR1ESR2MAPTALDH1A1CYP3A4
SCHEMBL3460804 0.87 ESR1 (0.50) ESR1ESR2MAPTALDH1A1CYP3A4
SCHEMBL5470663 0.85 ESR1 (0.58) ESR1ESR2MAPTALDH1A1CYP3A4
SCHEMBL49672 0.84 ESR1 (0.55) ESR1ESR2MAPTALDH1A1HSD17B10
SCHEMBL28808096 0.83 ESR1 (0.60) ESR1ESR2MAPTALDH1A1CYP3A4
SCHEMBL990339 0.82 ESR1 (0.63) ESR1ESR2MAPTALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212934-B1 Formation of a thin film of molecular organic semiconductor material CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS ETABLISSEMENT PUBLIC A CARACTERE SCIENTIFIQUE ET T (FR) 2019-09-04 EP disclosed
US-8758508-B2 Formation of a thin film of molecular organic semiconductor material CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2014-06-24 US disclosed
US-8492192-B2 Composition for forming an organic semiconducting device CREATOR TECHNOLOGY B.V. (NL) 2013-07-23 US disclosed
US-20120273734-A1 COMPOSITION FOR FORMING AN ORGANIC SEMICONDUCTING DEVICE CREATOR TECHNOLOGY B.V. (NL) 2012-11-01 US disclosed
US-8241946-B2 Method of forming an organic semiconducting device by a melt technique CREATOR TECHNOLOGY B.V. (NL) 2012-08-14 US disclosed
EP-1743390-B1 METHOD OF FORMING AN ORGANIC SEMICONDUCTING DEVICE BY A MELT TECHNIQUE CREATOR TECHNOLOGY BV (NL) 2011-07-27 EP disclosed
US-20110139063-A1 FORMATION OF A THIN FILM OF MOLECULAR ORGANIC SEMICONDUCTOR MATERIAL COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2011-06-16 US disclosed
EP-2212934-A1 FORMATION OF A THIN FILM OF MOLECULAR ORGANIC SEMICONDUCTOR MATERIAL Centre National de la Recherche Scientifique (CNRS) Etablissement Public à Caractère Scientifique et Technologique (FR) 2010-08-04 EP disclosed
WO-2009053473-A1 FORMATION OF A THIN FILM OF MOLECULAR ORGANIC SEMICONDUCTOR MATERIAL CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2009-04-30 WO disclosed
US-20080254568-A1 Composition and Method of Forming a Device KONINKLIJKE PHILIPS ELECTRONICS, N.V. (NL) 2008-10-16 US disclosed
EP-1743390-A1 METHOD OF FORMING AN ORGANIC SEMICONDUCTING DEVICE BY A MELT TECHNIQUE Koninklijke Philips Electronics N.V. (NL) 2007-01-17 EP disclosed
WO-2005104265-A1 METHOD OF FORMING AN ORGANIC SEMICONDUCTING DEVICE BY A MELT TECHNIQUE KONINKLIJKE PHILIPS ELECTRONICS, N.V. (US) 2005-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120273734-A1 COMPOSITION FOR FORMING AN ORGANIC SEMICONDUCTING DEVICE DACH1, DSG1, DSP ESR1 3832/4885ESR2 4466/4885MAPT 221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.